Asarfi Hospital delivered exceptional financial performance in the December 2025 quarter, with consolidated net profit surging 102.24% to ₹5.42 crore compared to ₹2.68 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this represents a remarkable turnaround in the hospital's profitability metrics during the quarter ended December 2025. The company's profit before tax (PBT) increased 106% to ₹7.45 crore from ₹3.62 crore in the corresponding quarter of the previous year, reflecting strong bottom-line performance that demonstrates the company's effective cost control measures and operational improvements.
The company's sales revenue increased 40.16% to ₹46.10 crore in Q3 FY2026, up from ₹32.89 crore in the same period last year. As reported by Business Standard, this substantial revenue growth demonstrates the company's ability to expand its business operations and market presence during the quarter. The latest results show that revenue for the same quarter reached ₹46.10 crores, reflecting a growth of 40.16% compared to the previous year, indicating robust demand for the hospital's services and successful execution of its growth strategy.
Despite the significant revenue growth, operating profit margin (OPM) improved to 21.93%, marking the highest in seven quarters according to recent market reports. The company managed to improve its profit before depreciation and tax (PBDT) by 55% to ₹10.33 crore compared to ₹6.67 crore in Q3 FY2025, indicating enhanced operational efficiency and cost management strategies. PAT margin increased to 11.76%, up by 361 basis points year-on-year, demonstrating the company's ability to enhance operational efficiency while scaling its operations and positioning it well in the competitive healthcare sector.
The strong quarterly results have been well-received by the market, with the company's stock performing exceptionally well and significantly outperforming the broader market and its peers over the past year. However, recent trading shows some volatility, with Asarfi Hospital's stock price currently at ₹170.40, reflecting a decline of 4.99% as of February 15, 2026. Despite a strong annual return of 85.62% over the past year, the stock's recent performance indicates some caution among investors, with negative returns of 9.41% year-to-date and 1.79% over the past month. The stock has been underperforming relative to the sector, falling 8.63% over the past week compared to a 1.14% decline in the Sensex, though there is some increased investor participation with a 10.5% rise in delivery volume.
